Clinical Trial Update: A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of tamoxifen and letrozole for recurrent and persistent squamous cell carcinoma of the cervix. The regist…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Cervix

Drugs mentioned

• Letrozole (letrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Uterine Cervical Neoplasms | Phase 2 | Status: UNKNOWN